148 related articles for article (PubMed ID: 17651380)
1. Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety.
Tabar AI; Lizaso MT; García BE; Gómez B; Echechipía S; Aldunate MT; Madariaga B; Martínez A
Pediatr Allergy Immunol; 2008 Feb; 19(1):67-75. PubMed ID: 17651380
[TBL] [Abstract][Full Text] [Related]
2. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled Alternaria alternata immunotherapy: in vivo and in vitro parameters.
Lizaso MT; Tabar AI; García BE; Gómez B; Algorta J; Asturias JA; Martínez A
Pediatr Allergy Immunol; 2008 Feb; 19(1):76-81. PubMed ID: 17662037
[TBL] [Abstract][Full Text] [Related]
4. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
[TBL] [Abstract][Full Text] [Related]
7. Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers.
Leynadier F; Herman D; Vervloet D; Andre C
J Allergy Clin Immunol; 2000 Sep; 106(3):585-90. PubMed ID: 10984382
[TBL] [Abstract][Full Text] [Related]
8. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
[TBL] [Abstract][Full Text] [Related]
9. Ragweed immunotherapy in adult asthma.
Creticos PS; Reed CE; Norman PS; Khoury J; Adkinson NF; Buncher CR; Busse WW; Bush RK; Gadde J; Li JT
N Engl J Med; 1996 Feb; 334(8):501-6. PubMed ID: 8559203
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
Colás C; Monzón S; Venturini M; Lezaun A
J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of allergy to mushrooms].
Lizaso MT; García BE; Gómez B; Zabalegui A; Rodríguez MJ; Tabar AI
An Sist Sanit Navar; 2003; 26 Suppl 2():129-37. PubMed ID: 13679972
[TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy with a standardized cat dander extract: evaluation of efficacy in a double blind placebo controlled study.
Alvarez-Cuesta E; Berges-Gimeno P; González-Mancebo E; Fernández-Caldas E; Cuesta-Herranz J; Casanovas M
Allergy; 2007 Jul; 62(7):810-7. PubMed ID: 17573730
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children.
Kuna P; Kaczmarek J; Kupczyk M
J Allergy Clin Immunol; 2011 Feb; 127(2):502-508.e1-6. PubMed ID: 21281874
[TBL] [Abstract][Full Text] [Related]
15. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
16. Dermatophagoides pteronyssinus cluster immunotherapy. A controlled trial of safety and clinical efficacy.
Tabar AI; Muro MD; García BE; Alvarez MJ; Acero S; Rico P; Olaguíbel JM
J Investig Allergol Clin Immunol; 1999; 9(3):155-64. PubMed ID: 10412677
[TBL] [Abstract][Full Text] [Related]
17. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract.
Enrique E; Pineda F; Malek T; Bartra J; Basagaña M; Tella R; Castelló JV; Alonso R; de Mateo JA; Cerdá-Trias T; San Miguel-Moncín Mdel M; Monzón S; García M; Palacios R; Cisteró-Bahíma A
J Allergy Clin Immunol; 2005 Nov; 116(5):1073-9. PubMed ID: 16275379
[TBL] [Abstract][Full Text] [Related]
18. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus.
Tabar AI; Echechipía S; García BE; Olaguibel JM; Lizaso MT; Gómez B; Aldunate MT; Martin S; Marcotegui F
J Allergy Clin Immunol; 2005 Jul; 116(1):109-18. PubMed ID: 15990782
[TBL] [Abstract][Full Text] [Related]
19. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
[TBL] [Abstract][Full Text] [Related]
20. Tolerance of immunotherapy with a standardized extract of Alternaria tenuis in patients with rhinitis and bronchial asthma.
Tabar AI; Lizaso MT; García BE; Echechipía S; Olaguibel JM; Rodríguez A
J Investig Allergol Clin Immunol; 2000; 10(6):327-33. PubMed ID: 11206932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]